Patil, Mihir K.
Salazar, Carlos E.
Venkatesh, Kaushik P.
Milosavljevic, Sofia
Rohan, Thomas Z.
Charrow, Alexandra P.
Nambudiri, Vinod E.
Article History
Received: 12 February 2024
Revised: 12 February 2024
Accepted: 7 April 2024
First Online: 17 April 2024
Declarations
:
: Non-human subjects research determination by Mass General Brigham Institutional Review Board (Redcap #665). IRB approval status: Not applicable.
: Dr. Charrow has served in an advisory capacity or on advisory boards for Novartis, UCB, Q32, and Wedbush. All other authors declare that they have no conflicts of interest.